Repositorio Digital de la UPF
Publicación
Artículo científico (JournalArticle)
Interplay of walnut consumption, changes in circulating miRNAs and reduction in LDL-cholesterol in elders
The mechanisms underlying the lipid-lowering effect of nuts remain elusive. This study explores whether one-year supplementation with walnuts decreases LDL-cholesterol (LDL-C) by affecting the expression of circulating microRNAs (c-miRNA). In this sub-study of the Walnuts and Healthy Aging (WAHA) trial, we obtained fasting serum at baseline and at 1 year from 330 free-living participants (63-79 year, 68% women), allocated into a control group (CG, abstinence from walnuts, n = 164) and a walnut group (WG, 15% of daily energy as walnuts, ~30-60 g/d, n = 166). Participants in the WG showed a 1 year decrease in LDL-C (-9.07, (95% confidence interval: -12.87; -5.73) mg/dL; p = 0.010 versus changes in the CG). We conducted a miRNA array in eight randomly selected participants in the WG who decreased in LDL-C. This yielded 53 c-miRNAs with statistically significant changes, 27 of which survived the correction for multiple testing. When validating them in the full population, statistical significance lasted for hsa-miR-551a, being upregulated in the WG. In mediation analysis, the change in hsa-miR-551a was unrelated to LDL-C decrease. Long-term supplementation with walnuts decreased LDL-C independently of the changes in c-miRNA. The hsa-miR-551a upregulation, which has been linked to a reduced cell migration and invasion in several carcinomas, suggests a novel mechanism of walnuts in cancer risk., This work was supported by a grant from the California Walnut Commission, Folsom, CA, US (to J.S. and E.R.), by a “Manuel de Hoya” grant (2014) from the Sociedad Española de Arteriosclerosis, and by Fondo de Investigación Sanitaria–Fondo Europeo de Desarrollo Regional (grant no. PI15/01014) (all to A.S.-V.). M.-C.L.d.l.H. was supported by a post-doctoral research contract funded by the community of Madrid and the European Union (PEJD-2016/BIO-2781). A.G.-R. acknowledges the Marie Curie AMAROUT-II Europe Program. A.D. was supported by the Spanish Agencia Estatal de Investigación and European Feder Funds (AGL2016-78922-R) and Fundación Ramón Areces (CIVP18A3888), Madrid, Spain. These funding agencies had no input in the study design, data collection, analyses, or writing and submission of the manuscript.
Proyecto:
ES / 1PE AGL2016-78922-R